Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice

Transplantation

Volumn 85, Issue 2, 2008, Pages 264-269

  Katsumi, Hidemasa ^a   Nishikawa, Makiya ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Ischemia reperfusion; Liver; Nitric oxide; S nitrosothiol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; POLYETHYLENE GLYCOL CONJUGATED POLY S NITROSATED SERUM ALBUMIN; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD; ENZYME ACTIVITY; HEPATIC ARTERY; LIVER; LIVER ISCHEMIA; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; HEPATIC ARTERY; LIVER; MALE; MICE; MICE, INBRED STRAINS; NEUTROPHILS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE DONORS; POLYETHYLENE GLYCOLS; PORTAL VEIN; REPERFUSION INJURY;

EID: 38549101065     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31815e902b     Document Type: Article

References (35)

1. Delva E, Barberousse JP, Nordlinger B, et al. Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery 1984; 95: 309.
2. Marzi I, Takei Y, Knee J, et al. Assessment of reperfusion injury by intravital fluorescence microscopy following liver transplantation in the rat. Transplant Proc 1990; 22: 2004.
3. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109.
4. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524.
5. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181.
6. Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994; 74: 376-382.
7. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454.
8. Rodenas J, Mitjavila MT, Carbonell T. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes. Am J Physiol 1998; 274: C827.
9. Isobe M, Katsuramaki T, Hirata K, et al. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999; 27: 68: 803.
10. Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989; 10: 292.
11. Kanwar S, Tepperman BL, Payne D, et al. Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock 1994; 42: 135.
12. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991; 79: 115.
13. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by Kupffer cells and priming neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 1991; 15: 277.
14. Lee VG, Johnson ML, Baust J, et al. The roles of iNOS in liver ischemia-reperfusion injury. Shock 2001; 16: 355.
15. Tsuchihashi S, Kaldas F, Chida N, et al. FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am J Transplant 2006; 6: 2013.
16. Jaworski K, Kinard F, Goldstein D, et al. S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells. Eur J Pharmacol 2001; 425: 11.
17. Liu P, Xu B, Hock CE, et al. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 1998; 275: H2191.
18. Quintana AB, Rodriguez JV, Lenzi HL, Guibert EE. Effect of S-nitrosoglutathione (GSNO) added to the University of Wisconsin Solution (UW): Mast cell degranulation during normothermic reperfusion. Ann Hepatol 2004; 3: 113.
19. Richardson G, Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond) 2002; 102: 99.
20. Katsumi H, Nishikawa M, Yamashita F, Hashida M. Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-Nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo. J Pharmacol Exp Ther 2005; 314: 1117.
21. Katsumi H, Nishikawa M, Ma SF, et al. Physicochemical, tissue distribution, and vasodilation characteristics of nitrosated serum albumin: Delivery of nitric oxide in vivo. J Pharm Sci 2004; 93: 2343.
22. Kuramoto T, Nishikawa M, Thanaketpaisarn O, et al. Use of lipoplex-induced nuclear factor-kappaB activation to enhance transgene expression by lipoplex in mouse lung. J Gene Med 2006; 8: 53.
23. Yabe Y, Kobayashi N, Nishihashi T, et al. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther 2001; 298: 894.
24. Kosonen O, Kankaanranta H, Uotila J, Moilanen E. Inhibition by nitric oxide-releasing compounds of E-selectin expression in and neutrophil adhesion to human endothelial cells. Eur J Pharmacol 2000; 394: 149.
25. Aiba M, Takeyoshi I, Ohwada S, et al. Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs. J Am Coll Surg 2001; 193: 264.
26. Naito Y, Takagi T, Ichikawa H, et al. A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemiareperfusion injury in rats. Nitric Oxide 2004; 10: 170.
27. Takahashi Y, Ganster RW, Gambotto A, et al. Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1175.
28. Yanagida H, Kaibori M, Yoshida H, et al. Hepatic ischemia/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression. Shock 2006; 26: 162.
29. Peng HB, Rajavashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995; 270: 17050.
30. Hattori Y, Kasai K, Gross SS. NO suppresses while peroxynitrite sustains NF-kappaB: A paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res 2004; 63: 31.
31. Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270: 14214.
32. Matthews JR, Botting CH, Panico M, et al. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 1996; 24: 2236.
33. DelaTorre A, Schroeder RA, Kuo PC. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem Biophys Res Commun 1997; 238: 703.
34. D'Angio CT, Finkelstein JN. Oxygen regulation of gene expression: A study in opposites. Mol Genet Metab 2000; 71: 371.
35. Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: Molecular basis and biological significance. Oncogene 2006; 25: 6731.